NCT04618185View on ClinicalTrials.gov

Gut Imaging for Function & Transit in CF - GIFT-CF 3

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

October 21, 2020

Primary Completion Date

June 28, 2023

Study Completion Date

June 28, 2023

Conditions
Cystic Fibrosis
Interventions
DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

MRI to study gut function and transit without the risk of exposure to ionising radiation.

Trial Locations (1)

NG7 2UH

Nottingham University Hospitals NHS Trust, Nottingham

All Listed Sponsors
collaborator

Manchester Metropolitan University

OTHER

collaborator

Vertex Pharmaceuticals Incorporated

INDUSTRY

lead

Nottingham University Hospitals NHS Trust

OTHER

NCT04618185 - Gut Imaging for Function & Transit in CF - GIFT-CF 3 | Biotech Hunter | Biotech Hunter